Document is current
Any future updates will be listed below
-
Authors
Semeere, Aggrey
Freeman, Esther
Wenger, Megan
Glidden, David
Bwana, Mwebesa
Kanyesigye, Micheal
Asirwa, Fredrick Chite
Rotich, Elyne
Busakhala, Naftali
Oga, Emmanuel
Jedy-Agba, Elima
Kwaghe, Vivian
Iregbu, Kenneth
Adebamowo, Clement
Jaquet, Antoine
Dabis, Francois
Phiri, Sam
Bohlius, Julia
Egger, Matthias
Yiannoutsos, Constantin T.
Wools-Kaloustian, Kara
Martin, Jeffrey
-
Funding
Funding for this research was provided by:
Eunice Kennedy Shriver National Institute Of Child Health & Human Development
President's Emergency Plan for AIDS Relief (PEPFAR) through the United States Agency for International Development (AID-623-A-12-0001)
Dermatology Foundation
National Institutes of Health (U01 AI096299, U01 AI069919, U01 AI069924, D43 CA153717, U54 CA190153, P30 AI027763, T32 AR007098)
National Institute On Drug Abuse
National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 21 March 2017
Accepted: 14 August 2017
First Online: 2 September 2017
Ethics approval and consent to participate
: Approval for this research was granted by each site’s institutional review board. Ethics Committees that approved this study: University of California, San Francisco; Indiana University; Partners Human Research Committee (Harvard); Moi University; Mbarara University of Science and Technology; University of Abuja Teaching Hospital; National Hospital of Abuja; and Malawi National Health Sciences Research Committee.
: Not Applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
